NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

PrEP at a Syringe Services Program

CompletedPhase 4

Sponsor: University of Miami

Conditions: Hiv, Substance Use Disorders

Interventions: Descovy 200Mg 25Mg Tablet, PrEP

Countries: United States

The purpose of this study is to see if providing participants with pre-exposure prophylaxis (PrEP) medicine right away at the IDEA Exchange will help participants remain in HIV negative.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

1. over the age of 18
2. speak either English or Spanish
3. ability to provide informed consent
4. currently enrolled in the syringe services program
5. have a negative HIV rapid test result
6. estimated creatinine clearance \> 30 ml/minute

Exclusion Criteria:

1. do not meet the above criteria of inclusion
2. decline to participate
3. test positive for HIV via rapid test
4. are pregnant or plan on becoming pregnant
5. have symptoms acute HIV.
6. Any other comorbidities that at the discretion of the investigator would prevent the participant from participating in the study.

Locations (1)

Miami, Florida, United States